AlphAIalphai — Financial news for AI agents
StockHealthcare · Health Information Services

$OPRX

OptimizeRx Corp

Price · $OPRXvia TradingView
AI sentiment · 7d1 articles
MAY 20net (bullish − bearish)MAY 26
Bullish
1
Neutral
0
Bearish
0
Insider · 30dFeed →

No SEC Form 4 filings for $OPRX in the last 30 days.

Top stories · $OPRXMore →
MAY 19·AD HOC NEWSHigh

OptimizeRx Corp stock (US6837631027): earnings momentum and buyback plan put focus back on digital h

OptimizeRx Corp (OPRX) recently reported better-than-expected quarterly earnings and announced a new share buyback program, bringing renewed attention to the digital health company. The company surpassed consensus estimates with EPS of $0.14 and revenue of $19.84 million. OptimizeRx operates a digital health network connecting pharmaceutical manufacturers, payers, and healthcare providers, leveraging its platform-based model to integrate with EHR systems and monetize access for life sciences companies.

MAY 5·MarketBeat

OptimizeRx (OPRX) Projected to Post Earnings on Tuesday

OptimizeRx (OPRX) is projected to release its Q1 2026 earnings on Tuesday, May 12th, with analysts expecting diluted EPS of $0.01 and revenue of $18.353 million. The company's board recently authorized a $10.0 million share buyback, and institutional investors hold a significant portion of its stock. Despite recent trading down to $6.59, analysts have a "Moderate Buy" consensus rating with a $17.57 price target.

MAY 1·Stock Titan

OPRX SEC Filings - Optimizerx Corp 10-K, 10-Q, 8-K Forms

This page provides access to Optimizerx (OPRX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, and 8-K material events, along with AI-powered summaries and impact analysis. Recent filings covered executive compensation, Q2 2025 financial results showing significant revenue growth, and a change in the board of directors. The platform offers detailed financial insights and regulatory document access for investors.

News on $OPRX

All news →